Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and rat
- 1 May 1991
- journal article
- research article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 142 (1) , 77-82
- https://doi.org/10.1111/j.1748-1716.1991.tb09130.x
Abstract
The relaxant effects of some isozyme‐selective phosphodiesterase inhibitors were evaluated in isolated human and rat coronary, lung and renal arteries. Milrinone and OPC 3911, inhibitors of a cGMP‐inhibited cAMP phosphodiesterase (cGI‐PDE), were shown to have distinct vasodilator actions. These agents were less potent as relaxants in rat lung and renal arteries than in the corresponding human tissues. OPC 3911, the more potent cGMP‐inhibited cAMP phosphodiesterase inhibitor, was found to be the more potent vasorelaxant. Rolipram, a selective inhibitor of a cGMP‐noninhibited cAMP phosphodiesterase, had small effects on coronary and lung arteries, but produced a slightly more pronounced relaxation of renal arteries from both man and rat. In human preparations contracted by 30 mm K+, milrinone and OPC 3911 had similar relaxant profiles, and were as potent in coronary as in renal arteries. These results do not support the notion that milrinone has reduced effects on renal vessels in man and show that there may be species differences in vascular responsiveness to cGMP‐inhibited cAMP phosphodiesterase inhibitors.Keywords
This publication has 14 references indexed in Scilit:
- Phosphodiesterase inhibition by new cardiotonic agents: Mechanism of action and possible clinical relevance in the therapy of congestive heart failureJournal of Molecular Medicine, 1989
- Relaxant Effects of the Selective Phosphodiesterase Inhibitors Milrinone and OPC 3911 on Isolated Human Mesenteric VesselsBasic & Clinical Pharmacology & Toxicology, 1989
- Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal ArteriesJournal of Cardiovascular Pharmacology, 1989
- Overview of cardiovascular physiologic and pharmacologic aspects of selective phosphodiesterase peak III inhibitorsThe American Journal of Cardiology, 1989
- Evidence for an A2 adenosine receptor in human coronary arteriesEuropean Journal of Pharmacology, 1988
- Is histamine a human coronary vasospastic substance?Trends in Pharmacological Sciences, 1987
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.Circulation, 1986
- Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.Circulation, 1986
- Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels*Acta Physiologica Scandinavica, 1983